Order Article Reprints

Pascolutti R, Yeturu L, Philippin G, Costa Borges S, Dejob M, Santiago-Raber M-L, Derouazi M. ATP128 Clinical Therapeutic Cancer Vaccine Activates NF-κB and IRF3 Pathways through TLR4 and TLR2 in Human Monocytes and Dendritic Cells. Cancers. 2022; 14(20):5134. https://doi.org/10.3390/cancers14205134

Pascolutti, Roberta, Lakshmi Yeturu, Géraldine Philippin, Stéphane Costa Borges, Magali Dejob, Marie-Laure Santiago-Raber, and Madiha Derouazi. 2022. "ATP128 Clinical Therapeutic Cancer Vaccine Activates NF-κB and IRF3 Pathways through TLR4 and TLR2 in Human Monocytes and Dendritic Cells" Cancers 14, no. 20: 5134. https://doi.org/10.3390/cancers14205134

Pascolutti, R., Yeturu, L., Philippin, G., Costa Borges, S., Dejob, M., Santiago-Raber, M. -L., & Derouazi, M. (2022). ATP128 Clinical Therapeutic Cancer Vaccine Activates NF-κB and IRF3 Pathways through TLR4 and TLR2 in Human Monocytes and Dendritic Cells. Cancers, 14(20), 5134. https://doi.org/10.3390/cancers14205134